Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Adbry
Pharma
Leo increases sales in US and bumps up 2025 revenue guidance
Leo reported that sales of eczema treatment Adbry are scaling up in the U.S. The company also made a positive adjustment to its 2025 sales guidance.
Kevin Dunleavy
Aug 19, 2025 12:38pm
Leo Pharma to chop or relocate 250 roles under ongoing revamp
Oct 9, 2024 4:28pm
Lilly secures FDA nod for atopic dermatitis therapy Ebglyss
Sep 16, 2024 11:16am
In year 2 under new CEO, troubled Leo Pharma makes progress
Mar 12, 2024 1:47pm
NICE recommends eczema drugs from AbbVie, Pfizer and Leo Pharma
Jun 30, 2022 8:30am
